CACrown ArchivesThe cinema collection
Menu
Research dossier · Science & Nature

Current Pharmaceutical Design

peer-reviewed scientific journal

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionOct 24, 2023
Entity authorityQ5195068
Source-derived summary

Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field.

The Journal is published by Bentham Science Publishers, which have faced criticism due to potentially predatory publishing tactics.

Abstracting and indexing

Current Pharmaceutical Design is abstracted and indexed in:

According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.208.

Editorial summary

“Current Pharmaceutical Design” enters the record as peer-reviewed scientific journal. Crown Archives preserves that source wording while asking what Current, Pharmaceutical and Design can confirm, complicate or overturn.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current lead gives the account dated anchors—2019—that can be checked directly. The linked authority record independently contributes the date 1995-01-01. Its strongest next move is a source search built around Current, Pharmaceutical and Design.
Editorial analysis

Why this record matters

“Current Pharmaceutical Design” is worth following because a concise public description often conceals a longer documentary argument. Here, Current, Pharmaceutical and Design provides the most credible route into that argument.

Evidence profile

The date and method of observation matter as much as the stated conclusion, especially where classification or consensus has changed. The source revision retrieved here is dated Oct 24, 2023. The linked authority identifier is Q5195068. 2 of 2 selected statements include explicit references; 1 carry qualifiers and 0 use preferred rank. The first chronological checks are 2019.

Critical limits

Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “Current Pharmaceutical Design”, its source revision and the description used here.
  2. Expand the search: follow Current Pharmaceutical Design primary sources, Current Pharmaceutical Design archive and Current research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Current Pharmaceutical Design”?
  2. Is the terminology current, historical or disputed?
  3. Has classification or technical consensus changed since the cited source?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Current Pharmaceutical Design” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.